GlobeNewswire by notified

Nexstim Receives an NBS System Upgrade Order from a Customer in the United States

Share

Press release, Helsinki, 28December 2021at 10 AM(EET)

Nexstim Receives an NBS System Upgrade Order from a Customer in the United States

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received an NBS 5+ system order from a customer in the United States.

Mikko Karvinen, CEO of Nexstim, comments: “Happy to announce this system sale to one of our existing customers.Our navigated TMS technology is a clear competitive advantage for us and a unique tool for our customers to use.Nexstim’s NBS 5+ system enables precise pre-operative mapping of the anatomic relationship of the surgical targets and essential functions in the brain as well as use in treating major depressive disorder.This new combined option aims to increase multi-departmental utilization of systems and facilitate innovation that may lead to future new therapeutic indications for both mental health and neurological conditions.

Further information is available on the website www.nexstim.com, or by contacting:

Mikko Karvinen, CEO
+358 50 326 4101
mikko.karvinen@nexstim.com

About Nexstim Plc

Nexstim is a Finnish, globally operating growth-oriented medical technology company. Our mission is to enable personalized and effective diagnostics and therapies for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS) with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain.

Nexstim’s Therapy Business markets and sells the Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain.

Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information, please visit www.nexstim.com

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

FutureDial Automation Solutions Process Over 231 Million Preowned Mobile Phones Worldwide25.1.2022 14:30:00 CET | Press release

Growing adoption of FutureDial’s robotics and automation software by Wireless Carriers, Third-Party Logistics Providers (3PLs) and Mobile Device Recyclers led to explosive volumes of preowned iPhones and Android Smartphones being processed for resale in 2021 SUNNYVALE, Calif., Jan. 25, 2022 (GLOBE NEWSWIRE) -- FutureDial Incorporated continued its commanding lead in providing mobile device processing solutions for Wireless Carriers, Mobile Device Buy-Back & Trade-In Companies, Mobile Phone Recyclers and Third-Party Logistics Providers (3PLs) during the year, announcing that its robotics and automation software solutions have been used by customers in the mobile supply chain to data clear, functionally test and grade a cumulative total of over 231.4 Million pre-owned Android smartphones and iPhones worldwide, for resale on secondary markets. Additionally, the total number of functional tests using FutureDial software and robotics for quality assurance performed on preowned iPhones and A

HMNC Brain Health Expands International Patent Portfolio with Two Stress-axis Related Substances for Major Depressive Disorder25.1.2022 14:30:00 CET | Press release

In-Licensing arrangement with the renowned Max Planck Society, extends patent protection for clinical research and strengthens Nelivabon and Cortibon developmental projects The Company has also established an office in the United States, furthering global expansion strategy MUNICH, Germany, Jan. 25, 2022 (GLOBE NEWSWIRE) -- HMNC Brain Health, (“HMNC” or the “company”), a clinical stage biopharmaceutical company pioneering the development of personalized therapies in psychiatry, announced that it has expanded its international patent portfolio in the field of psychiatric therapy with two patent families claiming substances for treating stress-axis related Major Depressive Disorder. These license agreements are part of a broader collaboration with the renowned Max-Planck-Society, comprising biomarker patent claims and therapeutic patent claims covering markets in Europe, the U.S., and now Asia, in particular Japan. Utilizing a more personalized approach to discovering new drugs in psychi

Mandalay Resources fortsätter att presentera utmärkta resultat från utvidgningsborrningen i Björkdalsgruvans östra del25.1.2022 14:25:01 CET | Pressemelding

Ådror med synligt guld och höga halter indikerar en uppgradering på djupet i Björkdal TORONTO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) har nöjet att meddela en uppdatering om utvidgningsborrningen i de östra delarna av Björkdalsverksamheten i Sverige. Nya borrningshöjdpunkter: Utvidgning av centrala området 47,7 g/t guld över 11,7 m (uppskattad sann bredd ”ETW” 5,85 m) i MU21-052: Inklusive 1 056,0 g/t över 0,40 m;47,5 g/t guld över 6,4 m (ETW 4,11 m) i MU21-047: Inklusive 716,0 g/t över 0,31 m; och507,0 g/t guld över 0,45 m (ETW 0,23 m) i MU21-051. Utvidgningstestning av centrala området 45,5 g/t guld över 2,3 m (ETW 1,15 m) i MU21-028;83,1 g/t guld över 0,4 m (ETW 0,39 m) i MU21-029;8,4 g/t guld över 5,7 m (ETW 5,35 m) in MU21-030; och5,1 g/t guld över 8,0 m (ETW 6,13 m) i MU21-031. Centralt område – Länk till Lake-området 13,2 g/t guld över 1,0 m (ETW 0,94 m) i MU21-028; och19,3 g/t guld över 0,4 m (ETW 0

Exterro Announces Significant Industry Promotion of its Document Review Platform25.1.2022 14:00:00 CET | Press release

Latest Version of Revamped Exterro Review Platform Optimized for Entire Legal Ecosystem; Limited-Time Only Promotion offers up to 6-Months Free Use of Platform PORTLAND, Ore., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Exterro Inc. – the preferred provider of Legal GRC software specifically designed for in-house legal, privacy, and IT teams at Global 2000 and AmLaw 200 organizations – today announced, for a limited-time only, a promotion of up to 6 free months and 5 terabytes of data storage of its Review platform. The promotion coincides with Exterro’s ongoing build out of its Review business unit and updated feature capabilities that are now available to the entire legal ecosystem, including legal service providers, law firms and corporate clients. Furthermore, the promotion of Clay Cocalis to Chief Revenue Officer and the addition of Don McLaughlin, Senior Vice President, Review Software represents the significant investment the company is placing in Exterro Review to ensure greater market s

Shareholders’ proposals to the Annual General Meeting for the number of Marimekko’s Board members, the composition of the Board and its remuneration25.1.2022 14:00:00 CET | Press release

Marimekko Corporation, Stock Exchange Release, 25 January 2022 at 3.00 p.m. Shareholders’ proposals to the Annual General Meeting for the number of Marimekko’s Board members, the composition of the Board and its remuneration Shareholders representing in total approximately 27% of all of Marimekko Corporation’s shares and votes have made a proposal to the Annual General Meeting to be held on 12 April 2022 for the number of members of the Board of Directors, the composition of the Board and its remuneration. Proposal for the number of members of the Board of Directors Shareholders who represent approximately 27% of all of Marimekko Corporation’s shares and votes have informed the company that they propose to the Annual General Meeting that six (6) members be elected to the Board of Directors. Proposal for the composition of the Board of Directors The above-mentioned shareholders have also informed the company that they propose that Carol Chen, Mika Ihamuotila, Mikko-Heikki Inkeroinen and

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS25.1.2022 11:07:00 CET | Press release

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS Auction date2022-01-25Loan2311Coupon1.00 %ISIN-codeSE0010948240Maturity2023-11-13 Tendered volume, SEK mln500 +/- 250 Volume offered, SEK mln1,357 Volume bought, SEK mln500 Number of bids4 Number of accepted bids1 Average yield0.067 %Lowest accepted yield0.067 %Highest yield0.067 %% accepted at lowest yield 100.00 Auction date2022-01-25Loan2611Coupon1.00 %ISIN-codeSE0012569572Maturity2026-11-12 Tendered volume, SEK mln500 +/- 250 Volume offered, SEK mln1,699 Volume bought, SEK mln500 Number of bids6 Number of accepted bids3 Average yield0.725 %Lowest accepted yield0.722 %Highest yield0.730 %% accepted at lowest yield 54.55 Auction date2022-01-25Loan2805Coupon0.75 %ISIN-codeSE0015660139Maturity2028-05-12 Tendered volume, SEK mln500 +/- 250 Volume offered, SEK mln2,462 Volume bought, SEK mln500 Number of bids11 Number of accepted bids4 Average yield0.957 %Lowest accepted yield0.954 %Highest yield0.970 %% accepted at lowest yield 64.